Join this live webinar to learn more.
For many patients with complex yet under‑diagnosed dermatology conditions, misdiagnosis or delayed diagnosis is common, translating into more pain and burden on quality‑of‑life.
In a marketplace where treatments exist but patients remain unseen, AI-powered real-world data is making it possible to proactively intervene and identify at-risk patients earlier to improve diagnosis, coordination of care, and screening for disease severity. Join this expert panel discussion to hear how OM1’s patient finding technology, paired with AAD’s DataDerm Registry, is empowering life science leaders to surface patient journey insights and drive clinician education around earlier diagnosis.
We’ll Discuss:
- How AI-powered patient finding works and can help improve the diagnosis gap
- The clinical need for improving early diagnosis in Dermatology and how AAD’s DataDerm Registry is enabling better dermatologic care and provider education
- A successful case study detailing how AI-powered patient finding helped Novartis gain new insights into the hidradenitis superativa (HS) patient journey
Who Should Attend:
This session is designed for clinicians and professionals in the pharma, biotech, and healthcare industries focused on Medical Affairs, Clinical Development, HEOR, and Market Access. If you want to learn more about earlier diagnosis or you’re working to improve patient outcomes, this webinar is for you.
Offered Free by: OM1, Inc.
See All Resources from: OM1, Inc.
